Inferior ST-Segment Elevation Can Predict In-Hospital Mortality in Patients with Anterior Myocardial Infarction

Xiaojuan Fan1, Shun Wang1, Ping Liu1

  • 1Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China.

Disease Markers
|July 25, 2022
PubMed

Insights

Electrocardiogram (ECG) findings in anterior myocardial infarction (MI) with ventricular septal rupture (VSR) are rarely studied. Inferior ST-segment elevation (STE) on ECG predicts higher in-hospital mortality in these complex MI patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Medical Diagnostics

Background:

  • Anterior wall myocardial infarction (MI) complicated by ventricular septal rupture (VSR) presents a rare but severe clinical challenge.
  • Electrocardiogram (ECG) findings in this specific patient cohort have not been extensively investigated.

Purpose of the Study:

  • To investigate the predictive value of specific ECG findings for in-hospital mortality in patients with anterior MI and VSR.
  • To identify key electrocardiographic markers associated with adverse outcomes in this high-risk population.

Main Methods:

  • A single-center retrospective study was conducted over ten years.
  • ECG data, including ST-segment elevation (STE) in inferior leads and new-onset right bundle branch block (RBBB), were analyzed.
  • Multivariate logistic regression was used to assess the independent predictors of in-hospital mortality.

Main Results:

  • Of 85 patients, 76.5% died in-hospital. Inferior STE was present in 41.2% of patients and was significantly associated with mortality (P = 0.005).
  • New-onset RBBB was observed in 29.4% of patients, but did not reach statistical significance for predicting mortality (P = 0.103).
  • Multivariate analysis identified inferior STE as an independent predictor of in-hospital death (OR: 14.488, P = 0.014).

Conclusions:

  • Inferior ST-segment elevation on ECG is a significant predictor of in-hospital mortality in patients experiencing anterior MI complicated by VSR.
  • These ECG findings can aid in risk stratification and early identification of high-risk patients requiring intensive management.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
70
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
326